Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Legal Issues
Enzo named senior party in U.S. Patent & Trademark Office proceeding
September 20th, 2006
Enzo Biochem, Inc. (ENZ) announced that the United States Patent and Trademark Office has declared two patent interferences designating an allowable Enzo Life Sciences patent application against patents held by Chiron Diagnostics and Princeton University for nucleic acid detection. Bayer Healthcare LLC, of Tarrytown, New York, is the real party in interest to Chiron's patent. Enzo Life Sciences is the senior party in both interferences. This nucleic acid technology is the basis for several significant products in clinical diagnostics and in the life sciences field which are currently marketed or licensed by various commercial companies. According to...
Source: Biotech Week (2006-09-20)
|
